PMID- 23236663
OWN - NLM
STAT- MEDLINE
DCOM- 20130118
LR  - 20121214
IS  - 0324-0959 (Print)
IS  - 0324-0959 (Linking)
VI  - 51
IP  - 3
DP  - 2012
TI  - [Therapeutic outcomes in patients with cervical cancer FIGO stage IB1].
PG  - 32-4
AB  - OBJECTIVE: To establish overall and disease-free survival (OS and DFS) for 
      patients with FIGO IB1 stage cervical cancer for median period of follow-up of 41 
      months. MATERIAL AND METHODS: Between 11.2002-11.2011 110 women with 
      histologically confirmed cervical cancer IB1 stage were operated on by the 
      author. Surgery was radical hysterectomy class III (Piver) and pelvic 
      lymphonodulectomy (ovariectomy was optionally). 76 patients were submitted to 
      adjuvant RT (TGT- 52 - 54 Gy). The period of follow-up ranges from 2 to 104 
      monts, median 41 monts. RESULTS: The acturial OS and DFS in patients with 
      cervical cancer IB1 stage were estimated as 90% and 90.9%, respectively. Eleven 
      patients had died for the period of follow-up and in 10 occurred local or distant 
      recurrences. The time to develop recurrences was estimated as 16.81 months. Four 
      patients developed local recurrences and six--distant metastases. CONCLUSION: 
      Surgical and combined therapy of cervical cancer patients IB1 stage leads to high 
      rate OS and DFS--90% and 90.9%, respectively. The incidence rate of distant 
      metastases (5.5%)--in six patients in this stage makes pelvic lymph node 
      dissection crucial and the presence of LM in gluteal and presacral lymph nodes 
      requires paraaortic lymph node dissection.
FAU - Kornovski, Y
AU  - Kornovski Y
FAU - Ismail, E
AU  - Ismail E
FAU - Kaneva, M
AU  - Kaneva M
LA  - bul
PT  - English Abstract
PT  - Journal Article
PL  - Bulgaria
TA  - Akush Ginekol (Sofiia)
JT  - Akusherstvo i ginekologiia
JID - 0370455
SB  - IM
MH  - Adult
MH  - Cervix Uteri/pathology/*radiation effects/*surgery
MH  - Disease-Free Survival
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Hysterectomy
MH  - Lymph Node Excision
MH  - Lymph Nodes/pathology/surgery
MH  - Lymphatic Metastasis/pathology/radiotherapy
MH  - Middle Aged
MH  - Neoplasm Grading
MH  - Pelvis/pathology/surgery
MH  - Radiotherapy, Adjuvant
MH  - Uterine Cervical Neoplasms/pathology/*radiotherapy/*surgery
EDAT- 2012/12/15 06:00
MHDA- 2013/01/19 06:00
CRDT- 2012/12/15 06:00
PHST- 2012/12/15 06:00 [entrez]
PHST- 2012/12/15 06:00 [pubmed]
PHST- 2013/01/19 06:00 [medline]
PST - ppublish
SO  - Akush Ginekol (Sofiia). 2012;51(3):32-4.